Peregrine Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.9M Buy
343,292
+13,162
+4% +$303K 0.24% 122
2025
Q1
$7.41M Buy
330,130
+9,362
+3% +$210K 0.25% 116
2024
Q4
$6.27M Buy
320,768
+5,759
+2% +$113K 0.19% 166
2024
Q3
$5.74M Buy
315,009
+819
+0.3% +$14.9K 0.17% 191
2024
Q2
$5.46M Buy
314,190
+32,311
+11% +$562K 0.16% 218
2024
Q1
$5.52M Buy
281,879
+58,640
+26% +$1.15M 0.16% 222
2023
Q4
$5.14M Sell
223,239
-66,975
-23% -$1.54M 0.15% 226
2023
Q3
$6.67M Buy
290,214
+35,948
+14% +$827K 0.2% 205
2023
Q2
$6.64M Buy
254,266
+68
+0% +$1.78K 0.18% 224
2023
Q1
$7.02M Sell
254,198
-20,269
-7% -$560K 0.2% 215
2022
Q4
$6.23M Buy
274,467
+63,942
+30% +$1.45M 0.2% 221
2022
Q3
$7.17M Sell
210,525
-63,191
-23% -$2.15M 0.23% 201
2022
Q2
$7.97M Sell
273,716
-30,839
-10% -$898K 0.24% 186
2022
Q1
$8.14M Sell
304,555
-22,457
-7% -$600K 0.19% 213
2021
Q4
$8.46M Buy
327,012
+9,416
+3% +$244K 0.17% 224
2021
Q3
$7.48M Buy
317,596
+11,392
+4% +$268K 0.16% 233
2021
Q2
$13.6M Buy
+306,204
New +$13.6M 0.24% 190